School of Paediatrics and Child Health, University of Western Australia, Nedlands, Western Australia, Australia.
J Heart Lung Transplant. 2011 Oct;30(10):1175-85. doi: 10.1016/j.healun.2011.06.007. Epub 2011 Jul 23.
Long-term survival after lung transplantation is hindered by the development of bronchiolitis obliterans syndrome (BOS), and recent evidence suggests that dysregulated epithelial repair may underlie its development. Because matrix metalloproteinase (MMP) -2 and MMP-9 secretion is integral to repair, we hypothesized that airway epithelial cells from patients with BOS would over-express these matrix-degrading enzymes.
Cells obtained from bronchial and bronchiolar brushings from patients with and without BOS (without acute rejection or infection) were analyzed via quantitative polymerase chain reaction and immunocytochemistry for MMP-2, and MMP-9 gene and protein expression. The expression of tissue inhibitor of metalloproteinase (TIMP)2 and TIMP1 was also assessed. MMP activity in bronchoalveolar lavage was determined via gelatin zymography.
MMP-2 and MMP-9 production was significantly higher in bronchoalveolar lavage (3.85- and 11.59-fold, p < 0.001) and airway epithelium (MMP-2 bronchial: 6.33-fold, bronchiolar: 3.57-fold, both p < 0.001; MMP-9 bronchial: 32.55-fold, p < 0.001; bronchiolar: 8.60-fold, p = 0.01) in patients with BOS, but expression in patients without BOS was not different from healthy controls. TIMP expression was similar in patients with and without BOS. Immunostaining confirmed that the airway epithelium was a direct source of MMP-2 and MMP-9 expression in patients with BOS.
In patients with BOS, the airway epithelium over-expresses MMPs, even in the absence of acute rejection or infection. Dysregulated epithelial repair may be a key feature of BOS.
肺移植后的长期存活受到闭塞性细支气管炎综合征(BOS)的发展的阻碍,最近的证据表明,上皮修复失调可能是其发展的基础。因为基质金属蛋白酶(MMP)-2 和 MMP-9 的分泌对于修复至关重要,所以我们假设 BOS 患者的气道上皮细胞会过度表达这些基质降解酶。
通过定量聚合酶链反应和免疫细胞化学,分析来自患有和不患有 BOS(无急性排斥或感染)的患者的支气管和细支气管刷取物中的细胞,以检测 MMP-2 和 MMP-9 基因和蛋白表达。还评估了组织金属蛋白酶抑制剂(TIMP)-2 和 TIMP-1 的表达。通过明胶酶谱法测定支气管肺泡灌洗液中的 MMP 活性。
BOS 患者的支气管肺泡灌洗液(3.85-和 11.59 倍,p < 0.001)和气道上皮(MMP-2 支气管:6.33 倍,细支气管:3.57 倍,均 p < 0.001;MMP-9 支气管:32.55 倍,p < 0.001;细支气管:8.60 倍,p = 0.01)中 MMP-2 和 MMP-9 的产生明显更高,但在没有 BOS 的患者中表达与健康对照者没有差异。TIMP 表达在有和没有 BOS 的患者中相似。免疫染色证实,BOS 患者的气道上皮是 MMP-2 和 MMP-9 表达的直接来源。
在 BOS 患者中,即使在没有急性排斥或感染的情况下,气道上皮也会过度表达 MMP。上皮修复失调可能是 BOS 的一个关键特征。